ARTICLE | Company News
Sequenom supply/service news
August 2, 2004 7:00 AM UTC
SQNM will restructure this quarter to focus on its Genetic Systems business unit, which includes its MassARRAY products. The company will discontinue its internal drug discovery efforts and close its Pharmaceuticals business unit. As part of the restructuring, SQNM will reduce its workforce by 50 positions, leaving a total of 160. ...